Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test (NCT06943768) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test
9,654 participantsStarted 2025-12-01
Plain-language summary
This is a multicenter, cross-sectional study. It is based on fecal methylation site detection, H. pylori susceptibility testing of fecal samples, and a combination of the two, compared with the "gold standard" imaging tests, CT, gastroscopy and/or pathology, for gastric cancer, benign diseases such as gastritis, and health check-ups.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years old, male or female not limited.
* Within 90 days, the gastroscopy and/or pathological results confirm the absence of gastric cancer.
* Patients must be able to fully understand the informed consent form and be able to personally sign it.
Exclusion Criteria:
* Severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders.
* A previous history of malignant tumors of the upper gastrointestinal tract.
* Women during pregnancy.
* Those with undefined pathology.
* Those with unsatisfactory sample retention (e.g., too small a sample size)